Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

NCT06111768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic

NCT03730961 ·Status: COMPLETED ·Phase: PHASE2

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

NCT07218627 ·Status: RECRUITING ·Phase: PHASE1

Effects of Acute and Chronic Empagliflozin Heart Failure

NCT05553938 ·Status: RECRUITING ·Phase: PHASE1

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

NCT01055912 ·Status: COMPLETED ·Phase: PHASE2

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

NCT05096143 ·Status: COMPLETED

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

NCT00259038 ·Status: COMPLETED ·Phase: PHASE2

Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure

NCT05419115 ·Status: COMPLETED ·Phase: PHASE2

Sub-Q Versus IV Furosemide in Acute Heart Failure

NCT02579057 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product

NCT02804282 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

NCT01120210 ·Status: COMPLETED ·Phase: PHASE2

Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot

NCT02877095 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

NCT00050076 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department

NCT06683053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

NCT00160134 ·Status: COMPLETED ·Phase: PHASE2

A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin

NCT06625307 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction

NCT05139615 ·Status: TERMINATED ·Phase: PHASE2

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

NCT04384653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients

NCT02689180 ·Status: UNKNOWN ·Phase: PHASE3

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

NCT04320771 ·Status: TERMINATED ·Phase: PHASE1

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

NCT03027960 ·Status: COMPLETED ·Phase: PHASE1

Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List

NCT06868797 ·Status: RECRUITING ·Phase: NA

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

NCT06307652 ·Status: RECRUITING ·Phase: PHASE3

Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine

NCT01373619 ·Status: COMPLETED ·Phase: PHASE4

A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs

NCT06708611 ·Status: WITHDRAWN ·Phase: PHASE4